好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Diagnosis of Electrographic Status Epilepticus by an Automated Seizure-burden Monitoring Algorithm and Its Association with Outcomes at Discharge
Neuro Trauma and Critical Care
P12 - Poster Session 12 (11:45 AM-12:45 PM)
7-007

To characterize the association between electrographic status epilepticus (ESE), as diagnosed by an automated algorithm, and functional outcomes at discharge.

Point-of-care electroencephalogram (POC EEG) helps triage seizure activity, and some systems are capable of running automated algorithms that monitor seizure burden (e.g. Clarity by Ceribell Inc.). Recently, FDA cleared an algorithm for the diagnosis of ESE in POC EEG recordings. Previous work has shown associations between functional outcomes at discharge and automated 5-min seizure burden.

We performed a cohort analysis on the retrospective SAFER-EEG trial.  The original study included hospitalized adult patients who received EEG monitoring across four academic centers.  Here, we included the POC EEG cases from three sites with valid outcome scores.  The ESE diagnosing algorithm was run post-hoc.  The discharge outcomes were categorized as unfavorable if the patient had modified Rankin Scale (mRS) score ≥ 4.  The odds of unfavorable outcome were estimated using a multivariate logistic regression, adjusting for demographics and clinical presentation pre-EEG.

From 359 patients included for analysis, 36 cases (10.0%) had ESE per the algorithm.  Patients with ESE were more likely to have admission diagnoses of acute brain injury (e.g. stroke, traumatic brain injury, inflammatory, etc.), post-cardiac arrest or history of epilepsy than those without a positive finding (75.0% vs. 65.3%, p = 0.004).  After adjusting for covariates, we found that patients with ESE diagnosis had increased odds of unfavorable outcomes at discharge compared to those without ESE (adj. OR = 3.0, 95% C.I. = 1.28-7.69, p = 0.014).  Some other variables that significantly affected the outcomes were age ≥ 65, mRS ≥ 4 pre-EEG, severe head injury, and having over 72h between admission and EEG start.

In a cohort of POC EEG patients, we showed significant associations between presence of ESE as determined by an automated algorithm and poor short-term functional outcomes.

Authors/Disclosures
Aaron F. Struck, MD (Washington University in St. Louis)
PRESENTER
The institution of Dr. Struck has received research support from Ceribell.
Mariel Kalkach Aparicio, MD Mariel Kalkach Aparicio, MD has nothing to disclose.
Masoom J. Desai, MD Dr. Desai has nothing to disclose.
Justine E. Cormier, MD Dr. Cormier has nothing to disclose.
Irfan S. Sheikh, MD (UT Southwestern) Dr. Sheikh has nothing to disclose.
Jorge A. Cespedes Mr. Cespedes has nothing to disclose.
Kaileigh Gallagher Ms. Gallagher has nothing to disclose.
M. B. Westover, MD, PhD (MGH) Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Lawrence J. Hirsch, MD, FAAN (Yale University Comprehensive Epilepsy Center) Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.